NRX Pharmaceuticals, Inc. Share Price
NRXPNRX Pharmaceuticals, Inc. Stock Performance
Open $4.36 | Prev. Close $4.28 | Circuit Range N/A |
Day Range $4.13 - $4.38 | Year Range $1.64 - $5.05 | Volume 12,517 |
Average Traded $4.25 |
NRX Pharmaceuticals, Inc. Share Price Chart
About NRX Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
NRX Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-Jul-26 | $4.36 | $4.17 | +0.00% |
20-Jul-26 | $4.36 | $4.17 | -2.00% |
17-Jul-26 | $4.12 | $4.26 | +0.35% |
16-Jul-26 | $4.38 | $4.25 | -4.61% |
15-Jul-26 | $4.41 | $4.45 | +2.30% |
14-Jul-26 | $4.21 | $4.35 | +4.82% |
13-Jul-26 | $4.09 | $4.15 | -0.95% |